|
|
|
|
| LEADER |
03021nam a22003615i 4500 |
| 001 |
000279683 |
| 005 |
20211026195540.0 |
| 007 |
cr nn 008mamaa |
| 008 |
100301s2008 xxu| s |||| 0|eng d |
| 020 |
|
|
|a 9780387743493
|
| 024 |
7 |
|
|a 10.1007/978-0-387-74349-3
|2 doi
|
| 040 |
|
|
|a Sistema de Bibliotecas del Tecnológico de Costa Rica
|
| 245 |
1 |
0 |
|a Cannabinoids and the Brain /
|c edited by Attila Köfalvi.
|
| 250 |
|
|
|a 1st ed. 2008.
|
| 260 |
# |
# |
|a New York, NY :
|b Springer US :
|b Imprint: Springer,
|c 2008.
|
| 300 |
|
|
|a XV, 583 p. :
|b online resource.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 505 |
0 |
|
|a Molecular Biology, Pharmacology, Anatomy, and Physiology of the Endocannabinoid and Related Lipidergic Signaling Systems in the Brain -- An Historical Introduction to the Endocannabinoid and Endovanilloid Systems -- Biosynthesis of Anandamide and 2-Arachidonoylglycerol -- Removal of Endocannabinoids by the Body: Mechanisms and Therapeutic Possibilities -- Other Cannabimimetic Lipid Signaling Molecules -- CB1 Cannabinoid Receptors: Molecular Biology, Second Messenger Coupling and Polarized Trafficking in Neurons -- CB2 Cannabinoid Receptors: Molecular, Signaling, and Trafficking Properties -- CB1 and CB2 Receptor Pharmacology -- Functional Molecular Biology of the TRPV1 Ion Channel -- Alternative Interacting Sites and Novel Receptors for Cannabinoid Ligands -- Anatomical Distribution of Receptors, Ligands and Enzymes in the Brain and in the Spinal Cord: Circuitries and Neurochemistry -- Endocannabinoids at the Synapse: Retrograde Signaling and Presynaptic Plasticity in the Brain -- Endocannabinoid Functions in Neurogenesis, Neuronal Migration, and Specification -- The Endocannabinoid System in Clinical Neuroscience and Experimental Neuropsychiatry -- Cannabinoids in the Management of Nausea and Vomiting -- Endocannabinoids in Energy Homeostasis and Metabolic Disorders -- Cannabinoids and Neuroprotection -- Neuroinflammation and the Glial Endocannabinoid System -- Targeting Cannabinoid Receptors in Brain Tumors -- Cannabinoids for the Control of multiple Sclerosis -- Endocannabinoids in Alzheimer's Disease -- The Endocannabinoid System as a Therapeutic Target in Epilepsy -- The Endocannabinoid System in the Physiology and Pathology of the Basal Ganglia -- The Endocannabinoid System is a Major Player in Schizophrenia -- The Cannabinoid Controversy: Cannabinoid Agonists and Antagonists as Potential Novel Therapies for Mood Disorders -- Role of Cannabinoid Receptors in Anxiety Disorders.
|
| 650 |
|
0 |
|a Pharmacology.
|
| 650 |
|
0 |
|a Neurosciences.
|
| 650 |
|
0 |
|a Neurology .
|
| 650 |
|
0 |
|a Psychiatry.
|
| 650 |
|
0 |
|a Psychopharmacology.
|
| 650 |
1 |
4 |
|a Pharmacology/Toxicology.
|
| 650 |
2 |
4 |
|a Neurosciences.
|
| 650 |
2 |
4 |
|a Neurology.
|
| 650 |
2 |
4 |
|a Psychiatry.
|
| 650 |
2 |
4 |
|a Psychopharmacology.
|
| 700 |
1 |
|
|a Köfalvi, Attila.
|e editor.
|
| 710 |
2 |
|
|a SpringerLink (Online service)
|
| 773 |
0 |
|
|t Springer eBooks
|